PRIYA PATEL: Open Payments
NPI 1659019453 · IRVING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 20 payments from 12 companies in 2025. Trend: 2023 $1,388 · 2024 $1,104 · 2025 $533
Food & beverage: $436Education: $97
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 3 | $154 |
| Calliditas Therapeutics US Inc. | 4 | $97 |
| Aurinia Pharma U.S., Inc. | 3 | $79 |
| Travere Therapeutics, Inc. | 2 | $40 |
| AKEBIA THERAPEUTICS INC | 1 | $28 |
| Ardelyx, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: ACTHAR, TARPEYO, LUPKYNIS, Vafseo, IBSRELA, VOYXACT, JARDIANCE, Fabhalta.
Industry payments across TX — which companies pay providers there.
